SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS

Biopharmaceutics and clinical pharmacokinetics

General Pharmacology The Vascular System · 1991 · 696 citations

Pharmacodynamics, Pharmacology, Clinical Pharmacokinetics +2

A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in Vitro

Richard P. Nordan, Michael Potter · Science · 1986 · 384 citations

Plasmacytoma Growth, Immunology, Pathology +17

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.

Matthew Peters, Samuel A. Jacobs, Marc Ehlers et al. · The Journal of Experimental Medicine · 1996 · 283 citations · Full text

Immune Regulation, Immunology, Immunologic Mechanism +19

Antitumor activity of recombinant interleukin 6 in mice.

James J. Mulé, Joe McIntosh, David M. Jablons et al. · The Journal of Experimental Medicine · 1990 · 227 citations · Full text

Il-6 Injections, Purified Human Ril-6, Antitumor Activity +17

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.

Jeffrey S. Weber, James Chih‐Hsin Yang, S L Topalian et al. · Journal of Clinical Oncology · 1993 · 217 citations